From : Maia Nikoleishvili
To : customer.service@mylan.com<customer.service@mylan.com> <customer.service@mylan.com>; customer.service@mylan.com; communications.inem@mylan.com<communications.inem@mylan.com> <communications.inem@mylan.com>; communications.inem@mylan.com
Subject : Request from MoH Georgia regarding procuring Remdesivir from Mylan
Cc : Tamar Gabunia <tgabunia@moh.gov.ge>
Received On : 10.10.2020 19:37

Dear Sirs,

I would like to kindly address you from the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia regarding procuring generic form of Remdesivir manufactured by Mylan under a license from Gilead Science Inc.

Considering current epidemiological situation, we are committed to use all existing opportunities, including engagement in the study of Remdesivir for the treatment of the patients with severe acute respiratory syndrome of COVID-19 in order to avoid fatal outcomes in the infected patients as far as possible.

Therefore, we urgently need to procurer  Remdesivir, initially sufficient for 500 eligible patients and kindly request you to provide us with the product price as well as terms and conditions of delivery as early as possible.

We rely on your support and do hope that our cooperation will be fruitful and successful.

Looking forward to receiving your feedback as soon as possible.

Sincerely yours,

 

Maia Nikoleishvili MPA

 

Head of International Relations and Protocol Division

Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia

Address: 144 Tsereteli ave., 0159 Tbilisi, Georgia

Tel.: +995 32 2510034 (0803)

Cell phone: +995 577272713

E-mail: mnikoleishvili@moh.gov.ge